Search Within

Gopakumar Vasudeva Iyer

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Meeting Abstract (128)
  2. Journal Article (77)
  3. Book Section (4)
  4. Review (2)
  5. Correspondence (1)
  6. Editorial (1)
  7. Research Letter (1)
Groups
  1. Department of Medicine (214)
  2. Department of Pathology and Laboratory Medicine (214)
  3. Genitourinary Oncology Service (214)
  4. Solid Tumor Oncology Division (214)
  5. Human Oncology and Pathogenesis Program (178)
  6. GSK Faculty (177)

More Groups

People
  1. Hikmat Al-Ahmadie (182)
  2. David Solit (171)
  3. Dean Bajorin (133)
  4. Jonathan Rosenberg (131)
  5. Bernard Bochner (120)
  6. Michael Berger (102)

More People

Years
  1. 2025 (8)
  2. 2024 (15)
  3. 2023 (12)
  4. 2022 (21)
  5. 2021 (19)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (64)
  2. Laboratory Investigation (27)
  3. Modern Pathology (20)
  4. Cancer Research (14)
  5. Clinical Cancer Research (10)
  6. European Urology (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (71)
  2. Nature Publishing Group (41)
  3. American Association for Cancer Research (26)
  4. Nature Research (20)
  5. Elsevier Inc. (15)
  6. Elsevier Science, Inc. (9)

More Publishers

Results (214)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • HER2 and PD-L1 immunohistochemistry (IHC) expression, and HER2 genomic alterations: Associations and clinical outcomes for advanced bladder cancer
    Meeting Abstract

    Aggen, D. H.; Shah, N. J.; Zheng, J.; Alam, S. M.; Balar, O.; Niederhausern, A.; Regazzi, A. M.; Ratna, N.; Funt, S. A.; Teo, M. Y.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • HER2 mutation and bladder cancer (BC): Prevalence and clinical outcomes
    Meeting Abstract

    Shah, N. J.; Aggen, D. H.; Zheng, J.; Niederhausern, A.; Alam, S. M.; Balar, O.; Bahadur, N.; Watson, A.; Regazzi, A. M.; Ratna, N.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Neoadjuvant nivolumab (N) + ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC): Updated results
    Meeting Abstract

    Sternschuss, M.; Guercio, B. J.; Pietzak, E. J.; Ponomarev, M.; Regazzi, A. M.; Quinlan, C.; Aggen, D. H.; Goh, A. C.; Cha, E. K.; Donat, S. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Defining molecular features associated with microsatellite instability and response to immune checkpoint blockade in urothelial carcinoma
    Meeting Abstract

    Alam, S. M.; Teo, M. Y.; Woo, J.; Sarfaty, M.; Funt, S. A.; Aggen, D. H.; Lee, C. H.; Carlo, M. I.; Gandhi, J.; Ratna, N.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Molecular, immunohistochemical and clinical determinants of urothelial carcinoma of the bladder with nested subtype
    Meeting Abstract

    Koll, F. J.; Basar, M.; Chen, Z.; Tin, A. L.; Alam, S. M.; Tallman, J. E.; Clinton, T. N.; Whiting, K.; Chen, J. F.; Sarungbam, J.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Correlation of peripheral blood monocytic myeloid-derived suppressor cells (M-MDSC) and T-cell receptor (TCR) dynamics with clinical outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with nivolumab (NIVO)
    Meeting Abstract

    Gupta, A.; Whiting, K.; Keegan, N. M.; Schmalz, J.; Al-Ahmadie, H. A.; Regazzi, A. M.; McCoy, A. S.; Maher, C. A.; Iyer, G.; Rosenberg, J. E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Differential NEUROD1, ASCL1, and POU2F3 expression defines molecular subsets of bladder small cell/neuroendocrine carcinoma with prognostic implications
    Journal Article

    Akbulut, D.; Whiting, K.; Teo, M. Y.; Tallman, J. E.; Ozcan, G. G.; Basar, M.; Jia, L.; Rammal, R.; Chen, J. F.; Sarungbam, J.; more...
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer
    Journal Article

    Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Genomic characterization of high-grade Ta urothelial carcinoma with and without carcinoma in situ
    Meeting Abstract

    Tallman, J. E.; Alam, S. M.; Koll, F.; Baky, F. J.; D'Souza, N.; de Jesus Escano, M.; Donahue, T. F.; Goh, A. C.; Sarungbam, J.; Berger, M. F.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • ERBB2 alterations in non-muscle invasive bladder cancer are associated with a distinct genomic signature
    Meeting Abstract

    Alam, S. M.; Tallman, J.; Koll, F.; D'Souza, N.; de Jesus Escano, M.; Donahue, T.; Goh, A.; Sarungbam, J.; Berger, M.; Schultz, N.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save